We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAscent Resources Regulatory News (AST)

Share Price Information for Ascent Resources (AST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.35
Bid: 2.30
Ask: 2.40
Change: 0.03 (1.29%)
Spread: 0.10 (4.348%)
Open: 2.25
High: 2.35
Low: 2.30
Prev. Close: 2.32
AST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Funding

1 Dec 2020 07:00

RNS Number : 0195H
Ascent Resources PLC
01 December 2020
 

1 December 2020

 

Ascent Resources plc

("Ascent" or the "Company")

New Funding

Ascent Resources Plc (LON: AST) the onshore Caribbean, Hispanic American and European focussed energy and natural resources company, is pleased to announce it has secured a new £500,000 loan facility.

New Funding

As announced on 29 October 2020, following a restructuring of the Company's balance sheet and historic obligations, the Company has a current debt balance of £270,020, which is due for maturity in February 2022.

The Company continues to make progress with its Cuban interests, Slovenian asset and claims under the Energy Charter Treaty and UK Slovenia Bilateral Investment Treaty as well as execution of its Special Situations Strategy. To facilitate further progress whilst minimising equity dilution, the Company has signed a loan agreement arranged and managed by Align Research Limited ("Align") to provide, in aggregate, £500,000 through an unsecured loan facility ("Loan Facility" or "Loan") provided equally by Align and RiverFort Global Opportunities PCC Ltd ("Lenders"). The Loan Facility, which is aimed at minimising dilution to shareholders at current prices, provides for the loan to be drawn down in four tranches of £125,000 each on the first business day of January, February, March and April 2021 respectively. The Loan plus a fixed coupon of 8% is repayable in full, at the election of the Lenders, either in cash or in shares at 7.5 pence per share (41.5% premium to the closing bid price on 30 November), on 31 December 2021 (the "Repayment Date"). The only exception to this will be where the Lenders request part or all of the Loan and any coupon to be utilised as consideration in paying for the warrants.

Issue of 7.5p Warrants

As part of the Loan Facility, the Company will issue a total of 6,666,666 warrants to the Lenders (the "Warrants"). The Warrants are exercisable by paying a cash price of 7.5 pence per warrant share (a 41.5% premium to the closing bid price on 30 November), or at the future placing price of any subsequent fundraise during the first 12 months of the Warrants being issued, if lower than 7.5 pence. The Warrants expire three years from the signing of the Loan agreement. In the event the Company announces that it has reached an amicable settlement agreement with the Republic of Slovenia relating to its ECT claim on or before the 31 January 2021 then any undrawn balance of the loan shall be cancelled and on a pro rata basis up to half of any Warrants outstanding may be cancellable by the Company.

Drawdown of Final £100,000 Existing Loan Facility and Exercise of Existing Warrants

 

Additionally, the Company has drawn down the final tranche of £100,000 under the previous loan facility and Align has simultaneously exercised the attached warrants ("Exercised Warrants") which were previously announced on the 6 August 2020. Align is therefore being issued with 4,000,000 Exercised Warrants shares and 320,000 Loan Coupon shares and has voluntarily agreed to a 3 months lock in on these new shares. 

Issue of Equity & TVR

The Company has also agreed to issue 480,000 ordinary shares at 7.5 pence per share ("Supplier Shares") in respect of £36,000 invoice retaining Align for a twelve months research services. These shares are subject to a lock in period of 3 months.

The issue of the Supplier Shares, the Exercised Warrants shares and the Loan Coupon shares are being carried out within the Company's existing share authority to issue ordinary shares for cash. Application will be made to the London Stock Exchange for the Supplier Shares, the Exercised Warrants shares and the Loan Coupon shares to be admitted to trading on AIM and it is expected that the Supplier Shares, the Exercised Warrants shares and the Loan Coupon shares will be admitted to trading on AIM at 8.00 a.m. on or around 7 December 2020.

In accordance with the provision of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Company confirms that, following the issue of the Supplier Shares, Exercised Warrants shares, Loan Coupon shares and shares issued during the month under the Company's existing block admission, its issued ordinary share capital will comprise of 95,283,281 ordinary shares. All of the ordinary shares have equal voting rights and none of the ordinary shares are held in Treasury. The total number of voting rights in the Company will therefore be 95,283,281. The above figure may be used by shareholders as the denominator for the calculations to determine if they are required to notify their interests in, or change to their interest in, the Company.

Andrew Dennan, the Company's Chief Executive Officer, commented:

"We are pleased to have secured this flexible funding solution as we continue to progress our discussions in Slovenia alongside our growth initiatives across Cuba and multiple broader Special Situations. This is an important time for Ascent and this funding will help facilitate those key workstreams as we look to progress activities right across the portfolio."

 

Enquiries:

Ascent Resources plc

Andrew Dennan

 

Via Vigo Communications

 

WH Ireland, Nominated Adviser & Broker

James Joyce / Chris Savidge

0207 220 1666

Novum Securities, Joint Broker

John Belliss

 

0207 399 9400

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEURSARRUUAOUA
Date   Source Headline
18th Apr 20241:42 pmRNSGeoenergo Administration: RJOA Status & Claim
2nd Apr 20242:41 pmRNSConfirmation of Geoenergo d.o.o. administration
4th Mar 20243:25 pmRNSResults of General Meeting
28th Feb 202411:27 amRNSHolding(s) in Company
23rd Feb 20247:00 amRNSUpdate on ECT claim
5th Feb 20247:00 amRNSNotice of Record Date, GM & posting of Circular
1st Feb 202411:57 amRNSBlock listing Interim Review
19th Jan 20243:32 pmRNSUpdate on JV Partner’s Insolvency Proceedings
16th Jan 202410:34 amRNSHolding(s) in Company - Correction
15th Jan 20241:09 pmRNSHolding(s) in Company
15th Jan 20247:00 amRNSAscent Prevents JV Partner’s Immediate Insolvency
8th Jan 20243:13 pmRNSJV Partner Initiates Insolvency Proceedings
21st Dec 20237:00 amRNSUpgrade in Estimate of Revenue Recognition
1st Dec 20237:00 amRNSECT Claim Distribution Update
21st Nov 20231:30 pmRNSDirector Appointment
15th Nov 20235:41 pmRNSResult of GM
13th Nov 20232:40 pmRNSHolding(s) in Company
27th Oct 202312:22 pmRNSNotice of GM and ECT Claim Shareholder Discussion
26th Oct 20234:50 pmRNSHolding(s) in Company
25th Oct 202312:10 pmRNSSuccessful Revenue Recognition Arbitration
25th Oct 20237:00 amRNSDirectorate Change
19th Oct 20233:19 pmRNSHolding(s) in Company
17th Oct 202310:14 amRNSHolding(s) in Company
11th Oct 202310:35 amRNSCompletion of Strategic Investment & TVR
3rd Oct 20237:00 amRNSCornerstone investor & Collaboration Agreement
28th Sep 20237:00 amRNSInterim Results
22nd Sep 202312:07 pmRNSSlovenia ECT Claim: ATE insurance contracted
21st Sep 20233:35 pmRNSResult of General Meeting
18th Aug 20234:14 pmRNSNotice of General Meeting
8th Aug 20237:48 amRNSDiscussions with Amur Minerals Corporation
1st Aug 20237:00 amRNSBlock listing Interim Review
21st Jul 20237:54 amRNSFiling of ECT Damages Claim Memorial
30th Jun 20232:08 pmRNSResult of AGM
29th Jun 20238:04 amRNSFinal Results
7th Jun 20235:30 pmRNSNotice of Annual General Meeting
1st Jun 20231:05 pmRNSIntention to bid for Amur Minerals Corporation
1st Jun 20237:00 amRNSHolding(s) in Company
30th May 20233:35 pmRNSConcession Extension,Partner Dispute &Subscription
10th May 20232:04 pmRNSHolding(s) in Company
9th May 202311:06 amRNSHolding(s) in Company
2nd May 20231:32 pmRNSHolding(s) in Company
17th Apr 202311:47 amRNSRevenue Recognition
6th Apr 202312:00 pmRNSUpdate on Slovenia Operations
4th Apr 20237:00 amRNSUpdate on Disputes, Placing & TVR
21st Mar 20232:05 pmRNSBeryl International Subscription Update
13th Mar 20231:49 pmRNSHolding(s) in Company
23rd Feb 20237:00 amRNSStrategic Partnership, Equity Issue & TVR
3rd Feb 202311:33 amRNSUpdate on Slovenia Operations
1st Feb 202311:30 amRNSBlock listing Interim Review
22nd Dec 20227:00 amRNSDirector Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.